CN105997909A — 一种奥贝胆酸口崩片及其制备方法
Assigned to China Pharmaceutical University · Expires 2016-10-12 · 10y expired
What this patent protects
本发明属于药物制剂领域,具体涉及一种奥贝胆酸口腔崩解片及其制备方法。本发明的奥贝胆酸口腔崩解片由活性成分奥贝胆酸、填充剂、崩解剂、矫味剂、润滑剂组成,其重量百分比为:5‑12.5∶65‑75∶10‑20∶1‑6∶3‑7。本发明采用粉末直接压片法制备奥贝胆酸口崩片,工艺简单适合工业化大规模生产。本发明制备得到的奥贝胆酸口崩片其崩解时间、含量均匀度、稳定性等均符合药典标准。
USPTO Abstract
本发明属于药物制剂领域,具体涉及一种奥贝胆酸口腔崩解片及其制备方法。本发明的奥贝胆酸口腔崩解片由活性成分奥贝胆酸、填充剂、崩解剂、矫味剂、润滑剂组成,其重量百分比为:5‑12.5∶65‑75∶10‑20∶1‑6∶3‑7。本发明采用粉末直接压片法制备奥贝胆酸口崩片,工艺简单适合工业化大规模生产。本发明制备得到的奥贝胆酸口崩片其崩解时间、含量均匀度、稳定性等均符合药典标准。
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.